As filed with the Securities and Exchange Commission on September 29, 2026

Registration No. [●]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM F-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

VCI GLOBAL LIMITED
(Exact Name of Registrant as Specified in its Charter)

Suite 33.03 of Level 33, Menara Exchange 106

Lingkaran TRX, Tun Razak Exchange,
55188 Kuala Lumpur, Malaysia
+603 3217 9898

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas 26th Floor

New York, New York 10036
Telephone: (212) 930-9700
(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to

Ross Carmel, Esq.

Jeffrey Wofford, Esq.

Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas 26th Floor

New York, New York 10036
Telephone: (212) 930-9700

Approximate date of commencement of proposed sale to the public: As soon as practicable after effectiveness of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

The information in this prospectus is not complete and may be changed. We may not sell the securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting any offer to buy these securities in any jurisdiction where such offer or sale is not permitted.

SUBJECT TO COMPLETION DATED SEPTEMBER [●], 2026

PRELIMINARY PROSPECTUS

VCI Global Limited 

(Incorporated in the British Virgin Islands)

Up to 111,573,730 Ordinary Shares

This prospectus relates to the offer and resale by Hudson Global Ventures, LLC (“Hudson”), or its permitted assigns, Dune Equity Holdings LLC (“Dune”), or its permitted assigns, and FirstFire Global Opportunities Fund LLC (“FirstFire”), or its permitted assigns (collectively, the “Selling Shareholders” and, individually, a “Selling Shareholder”), of up to an aggregate of 111,573,730 Ordinary Shares, no par value (“Ordinary Shares”), of VCI Global Limited, a British Virgin Islands corporation (the “Company”). The 111,573,730 Ordinary Shares (the Selling Shareholders Shares”) registered under the registration statement of which this prospectus forms a part (the “Registration Statement”) consist of (i) up to 100,000,000 Ordinary Shares (the “ELOC Purchase Shares”) that may be issued and sold to Hudson from time to time pursuant to the Equity Purchase Agreement (the “EPA”) dated September 23, 2026 between the Company and Hudson; (ii) up to 1,171,875 Ordinary Shares (the “ELOC Warrant Shares”) issuable upon exercise of warrants (the “ELOC Warrant”) issued to Hudson in connection with the execution of the EPA; (iii) up to 2,591,464 Ordinary Shares (the “Dune Conversion Shares”) issuable upon conversion of the secured convertible promissory note issued to Dune (the “Dune Note”) pursuant to the Securities Purchase Agreement dated September 23, 2026 between the Company and Dune (the “Dune SPA”); (iv) up to 2,591,464 Ordinary Shares (the “FirstFire Conversion Shares” and together with the Dune Conversion Shares, the “Conversion Shares”) issuable upon conversion of the secured convertible promissory note issued to FirstFire (the “First Fire Note” and together with the Dune Note, the “Notes”) pursuant to the Securities Purchase Agreement dated September 23, 2026 between the Company and FirstFire (the “FirstFire SPA” and together with Dune SPA, the “SPAs”) (v) up to 3,472,561 Ordinary Shares (the “Dune Warrant Shares”) issuable upon exercise of warrants (the “Dune Warrant”) issued to Dune pursuant to the Dune SPA; (vi) up to 1,710,366 Ordinary Shares (the “FirstFire Warrant Shares” and together with the Dune Warrant Shares, the “PIPE Warrant Shares”) issuable to FirstFire upon exercise of warrants (the “FirstFire Warrant” and together with the Dune Warrant, the “PIPE Warrants”) issued to FirstFire pursuant to the FirstFire SPA; (vii) 18,000 Ordinary Shares (the “Dune Commitment Shares”) issued to Dune as commitment fee for entering into the Dune SPA and (viii) 18,000 Ordinary Shares (the “FirstFire Commitment Shares”) issued to FirstFire as a commitment fee for entering into the FirstFire SPA (the “FirstFire Commitment Shares” and together with the Dune Commitment Shares, the “Commitment Shares”). The ELOC Warrant is a five year warrant with an exercise price of $0.01 per share. The PIPE Warrants are five year warrants with an initial exercise price of $2.00 per share (subject to a cashless exercise option) and are subject to adjustment for certain issuances of securities by the Company as described under “The ELOC Transaction and the Dune and FirstFire Convertible Note Transactions.”

See “The ELOC Transaction and the Dune and FirstFire Convertible Note Transactions” for a description of the EPA, the related Registration Rights Agreement, the ELOC Warrant, the SPAs, the Notes, the PIPE Warrants and the Security Agreement, and “Selling Shareholders” for additional information regarding the Selling Shareholders.

The prices at which the Selling Shareholders may resell the Selling Shareholder Shares will be determined by prevailing market prices or in negotiated transactions. We are not selling any securities under this prospectus and will not receive any proceeds from the resale of Selling Shareholder Shares by any Selling Shareholder. However, we may receive up to $125 million and $11,718.75 in proceeds from Hudson in connection with the sale of Ordinary Shares under the EPA and the exercise of the ELOC Warrant, respectively, and up to $1.7 million in aggregate proceeds from Dune and FirstFire in connection with exercises of the PIPE Warrants. We will not receive any proceeds from the issuance of the Conversion Shares or the Commitment Shares. We provide more information about how the Selling Shareholders may sell their Ordinary Shares in the section of this prospectus entitled “Plan of Distribution.” You should read this prospectus and any additional prospectus supplement or amendment carefully before you invest in our securities.

Hudson is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”). Dune and FirstFire may be deemed “underwriters” within the meaning of Section 2(a)(11) of the Securities Act. 

The Selling Shareholders will pay all brokerage fees and commissions and similar expenses. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred in registering the Selling Shareholder Shares, including legal and accounting fees. See “Plan of Distribution.”

Our Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “VCIG.” On September 28, 2026, the last reported sale price of our Ordinary Shares on Nasdaq was $1.625 per share.

You should read this prospectus, together with additional information described under the headings “Risk Factors” and “Where You Can Find More Information” carefully before you invest in any of our securities.

This offering will terminate on the earlier of (i) the date when all of the securities registered hereunder have been sold pursuant to this prospectus or Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), and (ii) the date on which all of such securities may be sold pursuant to Rule 144 without volume or manner-of-sale restrictions, unless we terminate it earlier.

Investing in our securities involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 9 to read about factors you should consider before buying our securities.

We are an “emerging growth company” as defined under the federal securities laws and may elect to comply with reduced public company reporting requirements. Please read “Implications of Our Being an Emerging Growth Company” beginning on page 5 of this prospectus for more information.

We are a “foreign private issuer” as defined under the federal securities laws and, as such, are subject to reduced public company reporting requirements. Please read “Foreign Private Issuer Status” beginning on page 6 of this prospectus for more information.

Neither the Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

TABLE OF CONTENTS

You should rely only on information contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. Neither the delivery of this prospectus nor the sale of our securities means that the information contained in this prospectus or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus. This prospectus is not an offer to sell or the solicitation of an offer to buy our securities in any circumstances under which the offer or solicitation is unlawful or in any state or other jurisdiction where the offer is not permitted. The information contained in this prospectus is accurate only as of its date regardless of the time of delivery of this prospectus or of any sale of our subordinate voting shares.

No person is authorized in connection with this prospectus to give any information or to make any representations about us, the securities offered hereby or any matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation is given or made, such information or representation may not be relied upon as having been authorized by us.

For investors outside the United States: Neither we nor the Selling Shareholders have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.

Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity and market share, is based on information from our own management estimates and research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge, which we believe to be reasonable. Our management’s estimates have not been verified by any independent source, and we have not independently verified any third-party information. In addition, assumptions and estimates of our and our industry’s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk Factors.” These and other factors could cause our future performance to differ materially from our assumptions and estimates. See “Cautionary Note Regarding Forward-Looking Statements.”

We obtained statistical data, market data and other industry data and forecasts used in this prospectus from market research, publicly available information and industry publications. While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data.

Throughout this prospectus, we refer to various trademarks, service marks and trade names that others use in their business. All rights to such trademarks are the property of their respective holders.

Throughout this prospectus, unless otherwise designated or the context suggests otherwise

While we maintain our books and records in U.S. dollars, the presentation currency for our financial statements and also our functional currency, as a holding company, our material assets are our direct equity interests in our subsidiaries, and we are therefore dependent upon the results of operations of our subsidiaries, which are denominated primarily in the Malaysian Ringgit (RM), and as such our consolidated results of operations may be affected by changes in the local exchange rates to the U.S. dollar.

RISK FACTORS

Investing in our securities involves a high degree of risk. Before deciding whether to purchase any of our securities, you should carefully consider the risks and uncertainties described below, in the section titled “Risk Factors” in our Annual Report on Form 20-F, and in other documents that we subsequently file with the Securities and Exchange Commission (the “SEC”) that update, supersede or supplement such information, which are incorporated by reference into this prospectus, and in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks actually occur, our business, financial condition and results of operations could be materially and adversely affected and we may not be able to achieve our goals, the value of our securities could decline and you could lose some or all of your investment. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks occur, the trading price of our Ordinary Shares could decline materially and you could lose all or part of your investment.

Risks Related to the Resale of the Selling Shareholder Shares 

The sale and issuance of Ordinary Shares under the EPA or the issuance of Ordinary Shares under the Notes, and the resale of those Selling Shareholder shares by the Selling Shareholders, may cause substantial dilution and may cause the price of our Ordinary Shares to decline.

On September 23, 2026, we entered into the EPA, pursuant to which Hudson has committed to purchase up to $125 million of our Ordinary Shares. Upon the execution of the ELOC Purchase Agreement, we issued the ELOC Warrant to purchase 1,171,875 Ordinary Shares at an exercise price of $0.01 per share as a fee for its commitment to purchase shares of our common stock under the EPA. The ELOC Purchase Shares that may be issued under the EPA may be sold by us to Hudson at our sole discretion from time to time over a 36-month period commencing after the satisfaction of certain conditions set forth in the EPA. The purchase price for the shares that we may sell to Hudson under the EPA will fluctuate based on the trading price of our Ordinary Shares. Depending on market liquidity at the time, sales of such shares may cause the trading price of our Ordinary Shares to decrease. We generally have the right to control the timing and amount of any future sales of our shares to Hudson. Additional sales of our common stock, if any, to the Hudson will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Hudson all, some or none of the additional shares of our common stock that may be available for us to sell pursuant to the EPA. If and when we do sell shares to Hudson, after Hudson has acquired the shares, Hudson may resell all, some or none of those shares at any time or from time to time in its discretion. Therefore, sales to Hudson by us could result in substantial dilution to the interests of other holders of our Ordinary Shares.

On September 23, 2026, we also entered the SPAs and issued the Notes and the PIPE Warrants. The number of Ordinary Shares issuable under the Notes will be based on the conversion price which will fluctuate with the trading price our Ordinary Shares. The PIPE Warrants include anti-dilution and price protection provisions that could significantly reduce the exercise price of the PIPE Warrants and significantly increase the number of Ordinary Shares underlying the PIPE Warrants if the Company issues equity based securities at a price that is lower than the current exercise price of the PIPE Warrants.

The sale of a substantial number of Ordinary Shares to Hudson or the issuance of a substantial number of Ordinary Shares to Dune or FirstFire resulting the conversion of the Notes or the exercise of the PIPE Warrants or the anticipation of such sales or issuances, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.

Investors who buy shares at different times will likely pay different prices, and the sale or issuance of Ordinary Shares to the Selling Shareholders could cause the price of our Ordinary Shares to decline.

Pursuant to the EPA, we will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold to Hudson and Hudson will have the discretion to exercise the ELOC Warrant in varying amounts and dates. Under the Notes and PIPE Warrants, Dune and FirstFire will have the discretion to convert the Notes and exercise the PIPE Warrants in varying amounts and dates. If and when we do elect to sell ELOC Shares pursuant to the ELOC Purchase Agreement or Hudson decide to exercise the ELOC Warrant or Dune or FirstFire decide to convert the applicable Note or exercise the applicable PIPE Warrant, after the applicable Selling Shareholder has acquired such shares, it may resell all, some or none of such shares at any time or from time to time in its discretion and at different prices. As a result, investors who purchase shares from a Selling Shareholder in this offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase from a Selling Shareholder in this offering as a result of future sales made by us to the Selling Shareholder at prices lower than the prices such investors paid for their shares in this offering. Further, the sale of a substantial number of Selling Shareholder Shares by the Selling Shareholders, or anticipation of such sales, could cause the trading price of our Ordinary Shares to decline or make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise desire.

Our management will have broad discretion over the use of the net proceeds from the ELOC and the Dune and FirstFire transactions, and you may not agree with how we use the proceeds or the proceeds may not be invested successfully.

Management will have broad discretion as to the use of net proceeds received under the EPA, the Notes and the PIPE Warrants, and we could use those proceeds for purposes other than those contemplated at the time of this offering. Accordingly, you will be relying on the judgment of our management with regard to the use of those proceeds and will not have the opportunity, as part of your investment decision, to assess whether they are being used appropriately. It is possible that, pending their use, we may invest those proceeds in a way that does not yield a favorable, or any, return for us. The failure of our management to use the proceeds effectively could have a material adverse effect on our business, financial condition, operating results and cash flows.

We may issue additional equity or equity-linked securities in the future, which may result in additional dilution to you.

We may require additional capital in the future for new strategic initiatives and ongoing operations. To the extent that we raise additional capital by issuing equity securities, including securities exercisable for or convertible into Ordinary Shares, our existing shareholders’ ownership may experience substantial dilution, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as an Ordinary Shareholder.

THE ELOC TRANSACTION AND THE DUNE AND FIRSTFIRE CONVERTIBLE NOTE TRANSACTIONS

The ELOC Transaction

On September 23, 2026, we entered into the EPA with Hudson, pursuant to which we have the right, but not the obligation, to direct Hudson to purchase up to $125,000,000 in ELOC Purchase Shares upon satisfaction of certain terms and conditions contained in the EPA. Such sales of our Ordinary Shares, if any, will be subject to certain limitations, and may occur from time to time at our sole discretion over the approximately 36-month period commencing on the date of execution of the EPA, provided that certain conditions set forth below and in the EPA are satisfied.

Hudson has no right to require any sales by us, but Hudson is obligated to make purchases at our direction subject to certain conditions. There is no upper limit on the price per share that Hudson could be obligated to pay for ELOC Purchase Shares under the EPA. Actual sales of ELOC Purchase Shares to Hudson from time to time will depend on a variety of factors, including, among others, market conditions, the trading price of our Ordinary Shares and determinations by us as to the appropriate sources of funding for us and our operations. The net proceeds that we may receive under the EPA, if any, cannot be determined at this time, since it will depend on the frequency and prices at which we sell ELOC Purchase Shares to Hudson, our ability to meet the conditions of the EPA, and the other limitations, terms and conditions of the EPA and any impacts of the Beneficial Ownership Limitation.

The EPA contains customary representations, warranties, conditions and indemnification obligations of the parties.

Purchase of ELOC Purchase Shares

Under the EPA, after the satisfaction of certain conditions, we have the right to deliver a put notice (a “Put Notice”) to Hudson that directs Hudson to purchase an amount of ELOC Purchase Shares in an amount totaling at least $25,000 but not exceeding the lesser of (i) $2,500,000 or (ii) 200% of the average daily trading volume of the Ordinary Shares during the three trading days immediately before the date of the Put Notice multiplied by the lowest closing price of the Ordinary Shares during the three trading days immediately before the date of the Put Notice. The number of ELOC Purchase Shares issued pursuant to a Put Notice is also subject to the 4.99% beneficial ownership limitation applicable to Hudson.

The purchase price per share to be paid by the Selling Stockholder for the ELOC Shares included in a Put Notice will be ninety five percent (95%) of the lesser of (i) the average of the three lowest traded prices of the Company’s Common Stock during the five trading days immediately preceding the date of the Put Notice and the lowest traded price of the Ordinary Shares during the Valuation Period. “Valuation Period” means for any Put Notice, the period begging on the date (the “Put Date”) such Put Notice is delivered to Hudson and ending on the date that is three trading days after the applicable ELOC Purchase Shares are transferred to Hudson’s brokerage account.

The EPA imposes a cooldown period between Put Notices, beginning on the Put Date of the prior Put Notice and continuing through the date that is three trading days after the applicable ELOC Purchase Shares are transferred to Hudson’s brokerage account. A cooldown waiver trigger applies when the ELOC Purchase Shares included in the immediately prior Put Notice have been delivered and trading volume on a trading day during the applicable cooldown period exceeds 300% of the total ELOC Purchase Shares included in such Put Notice. At that time the Company may deliver an additional Put Notice to Hudson.

ELOC Warrant and Other Terms

As consideration for Hudson’s/commitment to enter into the EPA, we issued a common stock purchase warrant for 1,171,875 ELOC Warrant Shares at an exercise price of $0.01 per share. The warrant was issued on September 23, 2026, is exercisable during a five-year term and may be exercised in whole or in part, subject to its terms and the 4.99% beneficial ownership limitation. The ELOC Warrant Shares are included in the securities registered by this prospectus.

Conditions to ELOC Purchases

Hudson’s obligation to purchase ELOC Purchase Shares is subject to the satisfaction of the conditions in the EPA, including an effective Registration Statement, accurate representations and warranties, the Company’s performance of its covenants, no injunction or material adverse change, the Ordinary Shares shall have not been deemed to be a penny stock as defined in SEC Rule 240.3a51-1 (17 CFR § 240.3a51-1), no knowledge of any event more likely than not to have the effect of causing the Registration Statement to be suspended or otherwise ineffective, all of the Company’s Exchange Act reporting requirements have been complied with, continued trading and listing of the Ordinary Shares, compliance with the 4.99% beneficial ownership limitation, an officer’s certificate, timely SEC filings, DWAC eligibility, a sufficient share reserve, minimum trading-price requirements and the absence of bankruptcy proceedings or other events specified in the EPA.

Registration Rights

Under the Registration Rights Agreement, we are required to file the Registration Statement within 30 calendar days after September 23, 2026, covering the maximum number of ELOC Purchase Shares and ELOC Warrant Shares permitted under applicable SEC rules. We are required to cause the Registration Statement to be declared effective within 90 calendar days after September 23, 2026, or as soon as possible before then, and to keep it effective during the applicable registration period. We must file amendments or additional registration statements if necessary to register the securities covered by the transaction documents, subject to applicable SEC limits. The Company will bear the reasonable expenses of registration, listing and qualification.

Termination of the ELOC

The EPA will terminate on the earliest of (i) the date Hudson has purchased ELOC Purchase Shares equal to the $125 million Maximum Commitment Amount, (ii) 36 months after September 23, 2026, (iii) the date specified in a written termination notice delivered by the Company, subject to the EPA’s restrictions on termination during a Valuation Period or while Hudson holds ELOC Purchase Shares, (iv) the date the Registration Statement is no longer effective after its initial effectiveness, or (v) the commencement of specified bankruptcy or insolvency proceedings. Termination does not eliminate Hudson’s rights under the ELOC Warrant. The EPA and the related ELOC transaction documents are governed by Nevada law and provide for dispute resolution in Nevada.

Limitation on Equity Line of Credit and Variable Rate Transactions 

For the period beginning on September 23, 2026 and continuing until the later of (i) 6 months after that date or (ii) the date the EPA is no longer in effect, we may not, without Hudson’s prior written consent, enter into another equity line of credit or a Variable Rate Transaction with another party. “Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional Ordinary Shares either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the Ordinary Shares at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Ordinary Shares or (ii) issues securities at a future determined price, provided, however, that an equity line of credit shall not be deemed to be a Variable Rate Transaction.

Dilutive Effect

The following table illustrates the number of ELOC Purchase Shares and gross proceeds that could result if the Company received the full $125 million Maximum Commitment Amount at the indicated assumed ELOC Purchase Price. The assumed price is for illustration only and is not a prediction of the price that will apply to any Put. The table gives no effect to the 4.99% beneficial ownership limitation or the number of shares registered under this prospectus.

The ELOC Purchase Shares and ELOC Warrant Shares will be offered and issued to Hudson, the Dune Conversion Shares, Dune Warrant Shares and Dune Commitment Shares will be offered and issued to Dune, and the FirstFire Conversion Shares, FirstFire Warrant Shares and FirstFire Commitment Shares will be offered and issued to FirstFire, in each case in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act, and the resale of those securities is being registered by this Registration Statement.

The Dune and FirstFire Convertible Note Transactions

The SPAs

On September 23, 2026, we entered into the Dune SPA and the FirstFire SPA. Under the SPAs we agreed to issue the Notes the PIPE Warrants, and the Commitment Shares and execute separate security agreements in favor of Dune and FirstFire. The Dune Note and FirstFire Note are pari passu secured obligations. Upon the execution of the SPAs we issued the Commitment Shares to Dune and FirstFire in the amounts of 18,000 shares to each.

Each Note has a maximum principal amount of $850,000 and a purchase price of up to $775,000, reflecting an original issue discount of up to $75,000 per note. Each Note bears a one-time interest charge at a rate of 12% on the principal amount, up to $102,000 per note. Each note is funded in three tranches, with a purchase price of $258,333.33 and a principal amount of $283,333.33 per tranche. Each note tranche has a 12-month maturity. Each of Dune and FirstFire will also withhold $25,416.66 from the aggregate purchase price of the first two tranches of the applicable Note for the payment of legal fees and broker fees and $12,916.66 from the third tranche for the payment of broker fees. In the aggregate, the Notes have a maximum principal amount of $1,700,000, an aggregate purchase price of up to $1,550,000, an aggregate original issue discount of up to $150,000 and aggregate one-time interest of up to $204,000. The first tranche of Notes were purchased by Dune and FirstFire on September 23, 2026.

The second tranche of Notes are required to be funded if, within 30 calendar days after the date of the applicable SPA, no Event of Default or event that would become an Event of Default has occurred, the Company has not breached the applicable transaction documents, the Ordinary Shares are listed on the Nasdaq Capital Market and the Company is in compliance with Nasdaq listing standards, no uncured Nasdaq delisting or deficiency notice remains outstanding, and the Company has filed the Registration Statement with the SEC. Dune and FirstFire must fund the second tranche of the Notes within five business days after satisfaction of these conditions. At each closing, the applicable note’s principal amount increases by $283,333.33 and its accrued interest increases by $34,000.00.

The third tranche under each Note is required to be funded if, within 90 calendar days after the date of the applicable SPA, the corresponding no-default, no-breach, Nasdaq listing and compliance, and no-uncured-delisting conditions remain satisfied, the Registration Statement has been declared effective by the SEC. Dune and FirstFire must fund the third tranche of the Notes within five business days after satisfaction of these conditions. At each closing, the applicable note’s principal amount increases by $283,333.33 and its accrued interest increases by $34,000.00.

Additional Investment Right

Dune and FirstFire each have an Additional Investment Right exercisable in their sole discretion during the one-year period beginning on the date of the applicable SPA, to enter into an additional set of transaction documents on the same terms.

Limitation on Variable Rate Transactions

The SPAs prohibit the Company from effecting or entering into an agreement involving a Variable Rate Transaction until the date that is six (6) calendar months after the Notes are fully converted or fully repaid.

The SPAs contain customary representations, warranties, conditions and indemnification obligations of the parties.

The Notes

Conversion of the Notes

Dune and FirstFire may each convert all or any portion of the outstanding principal amount and interest under their respective Note at any time, subject to the applicable 4.99% Beneficial Ownership Limitation. For each Note, the conversion price per share is the greater of (x) $0.328 (the “Floor Price”) and (y) the lesser of the $2.00 or 82% of the average of the three lowest traded prices of the Ordinary Shares during the 15 Trading Days immediately preceding the applicable Conversion Date. However, if the result obtained from clause (y) above is below the Floor Price, and thereafter the holder of a Note converts such Note, such holder will be entitled to receive in addition to the Ordinary Shares received in such conversion, either cash or an increase to the principal amount of its Note, in each case, in an amount equal to (x) the number of Ordinary Shares they did not receive in such cashless exercise because of the Floor Price limitation multiplied by (y) the closing price of the Ordinary Shares on the date of the exercise notice; provided that if the option to add such amount to the Note is elected then an additional 10% premium shall be included in such amount.

Voluntary Prepayments

At any time prior to the maturity date Maturity Date of each respective tranche of Notes, the Company shall have a one-time right with respect to each such tranche, exercisable on five (5) Trading Days prior written notice to the holder of the Note, to prepay the Prepayable Portion (as defined below) of such tranche in accordance with the terms of the Notes. The “Prepayable Portion” of each Tranche shall mean 99% of the outstanding principal amount then due under such tranche and 100% of the accrued and unpaid interest then due under such tranche. The prepayment amount is equal to 110% of the Prepayable Portion.

Mandatory Prepayments

If, at any time prior to the full repayment or full conversion of all amounts owed under the Notes, the Company or any of the Company’s subsidiaries receives cash proceeds from the issuance of equity or debt or the sale of assets, the Company shall, within one (1) business day of Company’s or the subsidiaries’ receipt of such proceeds, inform Dune and FirstFire of or publicly disclose such receipt, following which Dune and First Fire shall have the right in their sole discretion to require the Company or the Subsidiaries to immediately apply up to 35% of such proceeds to repay all or any portion of the outstanding principal amount and interest (including any default interest) then due under the Notes.

Events of Default

The following are Events of Default under the Notes.

Upon the occurrence of any Event of Default, the Notes shall become immediately due and payable, and the Company shall pay to Dune and FirstFire, in full satisfaction of its obligations hereunder, an amount equal to the principal amount then outstanding plus accrued interest (including any default interest) through the date of full repayment multiplied by 135% (collectively the “Default Amount”), as well as all costs, including, without limitation, legal fees and expenses, of collection, all without demand, presentment or notice, all of which hereby are expressly waived by the Company. Dune or FirstFire may, in their sole discretion, with respect to their Note, convert all or any portion of such Note (including the Default Amount) into Ordinary Shares pursuant to the terms of this Note (for the avoidance of doubt, this shall apply even if such conversion occurs after the Maturity Date); provided the conversion price may not be lower than $0.328 per share. Dune and First Fire shall be entitled to exercise all other rights and remedies available at law or in equity.

The PIPE Warrants

On September 23, 2026, pursuant to the SPAs, we issued the PIPE Warrants, which initially represent the right to purchase in the aggregate 850,000 Ordinary Shares at an exercise price of $2.00 per share, which may be exercised on a cashless basis. The PIPE Warrants have a five (5) year term.

To the extent that on any date during the term of the PIPE Warrants, the Company issues any Ordinary Shares at a price that is lower than the exercise price of the PIPE Warrants or issues any securities that are convertible into or exercisable for Ordinary Shares and the conversion price or exercise price of such securities is less than the exercise price of the PIPE Warrants (any such issuance, a “Dilutive Issuance”), the exercise price of the PIPE Warrants will be lowered to the applicable issuance price, conversion price or exercise price of the securities being issued; provided however the exercise price of the PIPE Warrants cannot be adjusted to a price that is lower than the Floor Price. However, if a Dilutive Issuance is below the Floor Price, and thereafter the holder of a PIPE Warrant exercise such PIPE Warrant on a cashless basis, such holder will be entitled to receive in addition to the Ordinary Shares received in such cashless exercise, either cash or an increase to the principal amount of its Note, in each case, in an amount equal to 50% of (x) the number of Ordinary Shares they did not receive in such cashless exercise because of the Floor Price limitation multiplied by (y) the closing price of the Ordinary Shares on the date of the exercise notice. Upon adjustment of the exercise price of the PIPE Warrants, the number of Ordinary Shares underlying the PIPE Warrants will also be increased so that when multiplying the new exercise price of the PIPE Warrants with such increased aggregate number of Ordinary Shares, the amount of aggregate proceeds due to the Company from a full exercise of the PIPE Warrants would be the same as immediately prior to the exercise price reduction.

The Security Agreement

On September 23, 2026 the Company entered into separate Security Agreements with each of Dune and FirstFire (the “Security Agreements” and each a “Security Agreement”). The Security Agreement provide Dune and FirstFire a first priority security interest in all of the assets of the Company with certain exceptions provided for in the Security Agreements to secure the Company’s obligations under the Notes. The Notes rank pari passu with each other.

The foregoing transaction descriptions are qualified in their entirety by reference to the transaction documents filed as exhibits to the Registration Statement, including the EPA, the ELOC Warrant, the Registration Rights Agreement, the SPAs, the Notes, and the PIPE Warrants and the Security Agreements.

USE OF PROCEEDS

The Selling Shareholders will receive all proceeds from the resale of Selling Shareholder Shares offered under this prospectus. We will not receive proceeds from those resales. We may receive up to $125 million in gross proceeds under the EPA and up to $956,666.72 in aggregate net proceeds in connection with the issuance of tranches 2 and 3 of the Notes and up to $1.7 million from the exercise of the PIPE Warrants (if cashless exercise option is exercised). We will not receive proceeds from the issuance of the Conversion Shares or the issuance of the Commitment Shares. Any proceeds received from the issuance of ELOC Purchase Shares, the issuance of the Notes or the exercise of the PIPE Warrants are expected to be used for general corporate purposes, including working capital, technology development, digital asset and artificial intelligence initiatives, and general and administrative expenses.

DIVIDEND POLICY

On June 6, 2023, we declared a first single tier interim dividend of $0.01 per Ordinary Share. The dividend was paid out on July 31, 2023, to the shareholders whose names are on the record at the close of business on July 3, 2023. On July 31, 2023, we paid out dividends in the amount of $104,557.28 to our shareholders. While we paid dividends in 2023, we did not do so in the fiscal years ended December 31, 2024 and 2025.

Any future determination relating to our dividend policy will be made at the discretion of our Board and will depend on then existing conditions. Under BVI law, the directors of the company can approve a distribution at any time and of such amount as they think fit, provided that the resolution of directors authorizing the distribution must include a Solvency Statement that, in the opinion of the directors, the company will, immediately after the distribution, satisfy the solvency test set out in the BVI Business Companies Act, 2004, being that:

However, under the terms of the Notes, the Company may not make any cash dividends.

SELLING SHAREHOLDERS

This prospectus relates to the possible resale from time to time by the Selling Shareholders of any or all of the Selling Shareholder Shares that may be issued or issuable under the EPA, the ELOC Warrant, the SPAs, the Notes or the PIPE Warrants. For additional information regarding the issuance of Selling Shareholder Shares covered by this prospectus, see “The ELOC Transaction and the Dune and FirstFire Convertible Note Transactions” above. We are registering the Selling Shareholder Shares pursuant to the EPA, the related Registration Rights Agreement and the SPAs and the Notes in order to permit the Selling Shareholders to offer the Selling Shareholder Shares for resale from time to time. Except for the transactions described in this prospectus, none of Hudson, Dune or FirstFire has had any material relationship with us within the past three years.

The table below presents information regarding the Selling Shareholders and the Selling Shareholder Shares that each may offer from time to time under this prospectus. This table is prepared based on information supplied to us by the Selling Shareholders and reflects holdings as of September 29, 2026. The number of shares in the column “Maximum Number of Ordinary Shares to be Offered Pursuant to this Prospectus” represents all of the Selling Shareholder Shares that each Selling Shareholder may offer under this prospectus, including ELOC Purchase Shares, ELOC Warrant Shares, the Conversion Shares, the PIPE Warrant Shares, the Commitment Shares. Each Selling Shareholder may sell some, all or none of its Selling Shareholder Shares. We do not know how long any Selling Shareholder will hold the Selling Shareholder Shares before selling them, and we currently have no agreements, arrangements or understandings with any Selling Shareholder regarding the sale of any of the Selling Shareholder Shares.

Beneficial ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act and includes Selling Shareholder Shares with respect to which each Selling Shareholder has voting and investment power. The percentage of Ordinary Shares beneficially owned by each Selling Shareholder prior to the offering shown in the table below is based on 2,077,473 Ordinary Shares outstanding as of September 29, 2026. Because the ELOC Purchase Price and the Dune and FirstFire conversion prices are determined under variable formulas, the number of Selling Shareholder Shares that may actually be issued or sold may be fewer than the number of Selling Shareholder Shares being offered by this prospectus. The final column assumes the sale of all of the Selling Shareholder Shares offered by each Selling Shareholder pursuant to this prospectus.

PLAN OF DISTRIBUTION

The 111,573,730 Selling Shareholder Shares offered by this prospectus are being offered by Selling Shareholders. The Selling Shareholder Shares may be sold or distributed from time to time by the Selling Shareholders directly to one or more purchasers or through brokers, dealers or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to prevailing market prices, at negotiated prices or at fixed prices, which may be changed. The sale of the Selling Shareholder Shares offered by this prospectus could be effected in one or more of the following methods:

In order to comply with the securities laws of certain states, if applicable, the Selling Shareholder Shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the Selling Shareholder Shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state’s registration or qualification requirement is available and complied with.

Hudson Global Ventures, Dune and FirstFire are each an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

Hudson Global Ventures, Dune and FirstFire have informed us that they intend to use one or more registered broker-dealers to effect sales, if any, of the Selling Shareholder Shares they have acquired or may acquire under the EPA, the Dune SPA, the FirstFire SPA and the related securities. Those sales will be made at prices and on terms then prevailing or at prices related to the then-current market price. The Selling Shareholders have informed us that each broker-dealer will receive commissions that will not exceed customary brokerage commissions.

Hudson is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”). Dune and FirstFire may be deemed “underwriters” within the meaning of Section 2(a)(11) of the Securities Act. 

Brokers, dealers, underwriters or agents participating in the distribution of the Selling Shareholder Shares offered by this prospectus may receive compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the Selling Shareholder Shares sold by any Selling Shareholder through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of Selling Shareholder Shares sold by any Selling Shareholders may be less than or in excess of customary commissions. Neither we nor the Selling Shareholders can presently estimate the amount of compensation that any agent will receive from any purchasers of Selling Shareholder Shares sold by any Selling Shareholders.

We know of no existing arrangements between the Selling Shareholders or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the Selling Shareholder Shares offered by this prospectus.

We may from time to time file with the SEC one or more supplements to this prospectus or amendments to the Registration Statement to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, information relating to a particular sale of Selling Shareholder Shares offered by Hudson, Dune or FirstFire, including the names of any brokers, dealers, underwriters or agents participating in the distribution of Ordinary Shares by any Selling Shareholder, any compensation paid by any Selling Shareholder to those parties and any other required information.

We will pay the expenses incident to the registration under the Securities Act of the offer and sale of the Ordinary Shares covered by this prospectus by the Selling Shareholders.

We have agreed to indemnify the Selling Shareholders and certain other persons against certain liabilities in connection with the offering of Selling Shareholder Shares offered hereby, including liabilities arising under the Securities Act, or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. The Selling Shareholders have agreed to indemnify us against liabilities under the Securities Act that may arise from written information furnished to us by any Selling Shareholder specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

The Selling Shareholders have represented to us that they and their respective agents, representatives and affiliates have not, prior to the date of the applicable transaction documents, engaged in or effected any short sale of the Selling Shareholder Shares that establishes a net short position with respect to those shares. The Selling Shareholders have agreed that during the term of the EPA, Dune SPA and FirstFire SPA, none of them, nor any of their respective agents, representatives or affiliates, will enter into or effect any such transactions, subject to applicable law and the terms of those documents.

We have advised the Selling Shareholders that they are required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the Selling Shareholders, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this prospectus.

This offering will terminate on the date that all of the Selling Shareholder Shares offered by this prospectus have been sold by the Selling Shareholders.

The Selling Shareholder Shares are currently listed on the Nasdaq Capital Market under the symbol “VCIG.”

EXPENSES RELATING TO THIS OFFERING

Set forth below is an itemization of the total expenses in US dollars, excluding placement agent fees and estimated offering expenses, expected to be incurred in connection with this offering by us. With the exception of the SEC registration fee and the FINRA filing fee, all amounts are estimates.

LEGAL MATTERS

We are being represented by Sichenzia Ross Ference Carmel LLP with respect to legal matters of United States federal securities law. The validity of the Ordinary Shares offered by this prospectus and legal matters as to BVI law only will be passed upon for us by Carey Olsen (BVI) L.P. Sichenzia Ross Ference Carmel LLP may rely upon Carey Olsen (BVI) L.P. with respect to matters governed by British Virgin Islands law only.

EXPERTS

Our consolidated financial statements as of and for the year ended December 31, 2025 included in this prospectus by incorporation by reference to the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, filed on July 15, 2026, have been audited by SFAI Malaysia PLT, an independent registered public accounting firm, as stated in its report appearing therein. The consolidated financial statements as of December 31, 2024 and for the years ended December 31, 2024 and 2023 were audited by WWC, P.C. Such financial statements are included in reliance upon the reports of those firms given upon their authority as experts in accounting and auditing.

ENFORCEABILITY OF CIVIL LIABILITY

We are incorporated under the laws of the British Virgin Islands, and our officers and directors are residents outside the United States. Moreover, a majority of our consolidated assets are located outside the United States. Although we are incorporated outside the United States, we have agreed to accept service of process in the United States through our agent designated for that purpose. Nevertheless, substantially all of the consolidated assets owned by us are located outside the United States and any judgment obtained in the United States against us may not be enforceable outside the United States. There is no treaty between the United States and the British Virgin Islands providing for the reciprocal recognition and enforcement of judgments in civil and commercial matters and a final judgment for the payment of money rendered by any federal or state court in the United States based on civil liability, whether or not predicated solely upon the federal securities laws, would, therefore, not be automatically enforceable in the British Virgin Islands. There is uncertainty as to whether judgments of courts in the United States based upon the civil liability provisions of the federal securities laws of the United States would be recognized or enforceable in the British Virgin Islands. In making a determination as to enforceability of a judgment of the courts of the United States, the BVI courts would have regard to whether the judgment was final and conclusive and on the merits of the case, given by a court of law of competent jurisdiction, and was expressed to be for a fixed sum of money. In general, a foreign judgment would be enforceable in the BVI unless procured by fraud, or the proceedings in which such judgments were obtained were not conducted in accordance with principles of natural justice, or the enforcement thereof would be contrary to public policy, or if the judgment would conflict with earlier judgment(s) from British Virgin Islands or earlier foreign judgment(s) recognized in British Virgin Islands, or if the judgment would amount to the direct or indirect enforcement of foreign penal, revenue or other public laws. Civil liability provisions of the federal and state securities law of the United States permit the award of punitive damages against us, our directors and officers. BVI courts would not recognize or enforce judgments against us, our directors and officers to the extent that doing so would amount to the direct or indirect enforcement of foreign penal, revenue or other public laws. It is uncertain as to whether a judgment of the courts of the United States under civil liability provisions of the federal securities law of the United States would be regarded by BVI courts as being pursuant to foreign, penal, revenue or other public laws. Such a determination has yet to be made by a BVI court in a reported decision.

In addition, holders of book-entry interests in our shares will be required to exchange such interests for certificated shares and to be registered as shareholders in our shareholder register in order to have standing to bring a shareholder suit and, if successful, to enforce a foreign judgment against us, our directors or our executive officers in the BVI.

A holder of book-entry interests in our shares may become a registered shareholder of our Company by exchanging such holder’s interest in our shares for certificated shares and being registered in our shareholder register. The administrative process of becoming a registered shareholder could result in delays prejudicial to any legal proceeding or enforcement action.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the SEC a registration statement on Form F-1, including relevant exhibits and schedules under the Securities Act, covering the Securities offered by this prospectus. You should refer to our registration statements and their exhibits and schedules if you would like to find out more about us and about our Securities. This prospectus summarizes material provisions of contracts and other documents that we refer you to. Since the prospectus may not contain all the information that you may find important, you should review the full text of these documents.

We are subject to periodic reporting and other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, we are required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in Sections 14(a), (b) and (c) of the Exchange Act, and our executive officers, directors and principal shareholders are exempt from the short-swing profit recovery provisions contained in Section 16 of the Exchange Act.

Statements made in this prospectus concerning the contents of any contract, agreement or other document are not complete descriptions of all terms of these documents. If a document has been filed as an exhibit to the registration statement, we refer you to the copy of the document that has been filed for a complete description of its terms. Each statement in this prospectus relating to a document filed as an exhibit is qualified in all respects by the filed exhibit. You should read this prospectus and the documents that we have filed as exhibits to the registration statement of which this prospectus is a part completely.

As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.

The SEC maintains an internet website that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is http://www.sec.gov. The information on that website is not a part of this prospectus.

No dealers, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

The following documents filed by us with the Commission are incorporated by reference in this prospectus:

We also incorporate by reference all documents we file pursuant to Section 13 or Section 15(d) of the Exchange Act after the date of the initial registration statement of which this prospectus is a part and prior to effectiveness of such registration statement. All documents we file in the future pursuant to Section 13 or Section 15(d) of the Exchange Act after the date of this prospectus and prior to the termination of the offering are also incorporated herein by reference and are an important part of this prospectus.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

We will provide upon request to each person, including any beneficial owner, to whom a prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in the prospectus but not delivered with the prospectus. Our website address is https://v-capital.co. Information contained in our website is not part of this prospectus. You may request a copy of these filings, excluding the exhibits to such filings which we have not specifically incorporated by reference in such filings, at no cost, by writing to or calling us at:

Suite 33.03 of Level 33, Menara Exchange 106
Lingkaran TRX, Tun Razak Exchange
55188 Kuala Lumpur, Malaysia
+603 3217 9898

VCI Global Limited

(Incorporated in the British Virgin Islands)

PROSPECTUS

Up to 111,573,730 Ordinary Shares

[●], 2026

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 6. Indemnification of Directors and Officers.

British Virgin Islands law does not limit the extent to which a British Virgin Islands company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent that any such provision may be held by the British Virgin Islands courts as being contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.

Our Memorandum and Articles of Association contain provisions that entitle the Company to indemnify against all expenses, including legal fees, and against all judgments fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings, any person involved in legal proceeding by reason of the fact that the person is or was a director of the Company or the person, at the request of the Company, is or was serving as director, or any other capacity, of any other body corporate. The Company may only indemnify if the person acted honestly, in good faith, with a view to the best interest of the Company, and in the case of criminal proceedings, the person had no reasonable cause to believe that his conduct was unlawful. We believe that these provisions are necessary to attract and retain qualified persons as directors and officers. As a result of these provisions, the ability of the Company or a stockholder thereof to successfully prosecute an action against a director for a breach of his duty of care has been limited. However, the provision does not affect the availability of equitable remedies such as an injunction or rescission based upon a director’s breach of his duty of care.

Item 7. Recent sales of unregistered securities.

In the last three years, the registrant has granted or issued the following securities of the registrant that were not registered under the Securities Act:

(a) Issuances of Capital Stock.

On October 1, 2023, the Company issued 14,045 restricted shares of the Company’s Ordinary Shares, at a value of $3.56 per share, to Outside The Box Capital Inc., as their consideration pursuant to a marketing agreement.

In January 2024, April 2024 and May 2024 we issued an aggregate of 1,170,863 Company’s Ordinary Shares to our directors as compensation.

In March 2024, 6 Ordinary Shares (representing 11,191,047 shares before giving retroactive effect to the four rounds of reverse share splits) were issued to Sichenzia Ross Ference Carmel LLP as consideration for legal services rendered to the Company.

In April 2024, 1 Ordinary Share (representing 1,697,447 shares before giving retroactive effect to the four rounds of reverse share splits) was issued to Exchange Listing, LLC as true-up shares at approximately $1.73 per share (before the reverse share splits).

In May 2024, 5 Ordinary Shares (representing 8,000,000 shares before giving retroactive effect to the four rounds of reverse share splits) were issued to several third-party companies as prepayment for the development of proprietary software, including the Vendor and Customer Relationship Management system and Cloud Management Platform.

On July 2 and July 12, 2024, an aggregate of 3 Ordinary Shares (representing 3,900,603 shares before giving retroactive effect to the four rounds of reverse share splits) were issued to Boustead Securities LLC and Cogia GmbH as consideration for the acquisition of Socializer Messenger, a highly secure messaging platform.

In August 2024, we issued an aggregate 1 Ordinary Share (representing 227,762 shares before giving retroactive effect to the four rounds of reverse share splits) to our directors as compensation.

In 2024, an aggregate of 57 Ordinary Shares (representing 52,820,605 Ordinary Shares before giving retroactive effect to the applicable reverse share splits) were issued to Codetext Limited as prepayment for services rendered to the Company.

On December 11, 2024, 1 Ordinary Share (representing 48,316 shares before giving retroactive effect to three rounds of reverse share splits) was issued to three independent directors as gratuity payments for their past services upon their resignation.

From January 1 to December 13, 2024, an aggregate of 5 Ordinary Shares (representing 1,540,849 Ordinary Shares before giving retroactive effect to the applicable reverse share splits) were issued to executive directors and independent directors pursuant to their employment agreements.

From January 2 to January 7, 2025, an aggregate of 134 Ordinary Shares (representing 4,822,810 Ordinary Shares before giving retroactive effect to three rounds of reverse share splits) were issued to CEO Dato’ Hoo Voon Him pursuant to securities purchase agreements.

From January 7, 2025 until September 29, 2025, an aggregate of 1,571 Ordinary Shares (representing 3,351,943 Ordinary Shares before giving retroactive effect to the applicable reverse share splits) were issued to management staff, executive directors and independent directors pursuant to their employment agreements.

On January 7, 2025, 2 Ordinary Shares (representing 56,180 Ordinary Shares before giving retroactive effect to three rounds of reverse share splits) were issued to Carlson Thow pursuant to a legal consultancy services agreement.

On January 9, 2025, 1 Ordinary Share (representing 39,370 Ordinary Shares before giving retroactive effect to three rounds of reverse share splits) was issued to W Capital Markets Pte. Ltd. pursuant to an engagement letter to act as Arranger dated December 3, 2024.

On June 12, 2025, 846 Ordinary Shares (representing 1,522,288 Ordinary Shares before giving retroactive effect to the 1:30 and 1:60 reverse share splits) were issued to various investors as share pledges pursuant to a friendly loan agreement.

On June 26, 2025, 6,614 Ordinary Shares (representing 11,904,764 shares before giving retroactive effect to the 1:30 and 1:60 reverse share splits) were issued to various investors in exchange for a 20% ownership interest in Quantgold Data Group Limited.

From October 3, 2025 until October 22, 2025, 14,735 Ordinary Shares (representing 884,090 Ordinary Shares before giving retroactive effect to the 1:60 reverse share split) were issued as referral fees in connection with the introduction of new clients.

On November 10, 2025, 14,667 Ordinary Shares (representing 880,000 Ordinary Shares before giving retroactive effect to the 1:60 reverse share split) were issued to subscribe for Oobit tokens, the native utility token for the Oobit cryptocurrency.

On November 11, 2025, an aggregate of 104,569 Ordinary Shares (representing 6,274,169 shares before giving retroactive effect to the 1:60 reverse share split) were issued to certain executive officers pursuant to the Employee Stock Ownership Plan.

On February 24, 2026, 205,000 Ordinary Shares (representing 12,300,000 Ordinary Shares before giving retroactive effect to the 1:60 reverse share split) were issued to certain shareholders of Reveillon Group Limited as a deposit in connection with the Company’s right to acquire additional shares of Reveillon Group Limited.

On February 24, 2026, 295,000 Ordinary Shares (representing 17,700,000 Ordinary Shares before giving retroactive effect to the 1:60 reverse share split) were issued as referral fees in connection with the introduction of new projects and investors to the Group.

On March 11, 2026 and March 31, 2026, an aggregate of 218 Ordinary Shares (representing 3,270 Ordinary Shares before giving retroactive effect to the 1:15 reverse share split) were issued to Alex Chua Siong Kiat, an executive director, pursuant to his employment agreements.

On March 17, 2026, 47,367 Ordinary Shares (representing 710,509 shares before giving retroactive effect to the 1:15 reverse share split) were issued to certain executive officers pursuant to the Employee Stock Ownership Plan.

On April 6, 2026, 13,333 Ordinary Shares (representing 200,000 shares before giving retroactive effect to the 1:15 reverse share split) were issued to certain suppliers pursuant to commission agreements in connection with the referral of investors to the Group.

On April 30, 2026, 32,000 Ordinary Shares (representing 480,000 Ordinary Shares before giving retroactive effect to the 1:15 reverse share split) were issued to Brown Stone Capital Limited and Abri Advisory Limited as consideration for services rendered to the Company.

From May 20, 2026 until May 26, 2026, an aggregate of 123,609 Ordinary Shares (representing 1,854,135 Ordinary Shares before giving retroactive effect to the 1:15 reverse share split) were issued to CEO Dato’ Hoo Voon Him pursuant to private subscription agreements.

On June 3, 2026, 54,551 Ordinary Shares (representing 818,258 Ordinary Shares before giving retroactive effect to the 1:15 reverse share split) were issued to S2MA Capital to subscribe for Oobit tokens.

On March 11, 2026 and June 5, 2026, an aggregate of 47,800 Ordinary Shares (representing 717,000 Ordinary Shares before giving retroactive effect to the 1:15 reverse share split) were issued as referral fees in connection with the introduction of new projects and investors to the Group.

On September 24, 2026, the Company issued 18,000 Dune Commitment Shares to Dune. On September 24, 2026, the Company issued 18,000 FirstFire Commitment Shares to FirstFire.

These issuances of capital stock were deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder, as applicable, because they were made in transactions that did not involve a public offering. To the extent applicable, securities issued pursuant to a court-approved settlement were deemed exempt from registration under Section 3(a)(10) of the Securities Act. The recipients of such securities represented their intention to acquire the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof.

(b) Issuances of Warrants.

In March 2023, we issued a five-year warrant to purchase 250,000 Ordinary Shares to Exchange Listing, LLC as part of their consulting compensation. The exercise price is $4.00 per Ordinary Share.

In January 2024, the Company issued Series A Warrants and Series B Warrants, each to purchase up to 2,200,000 Ordinary Shares. The Series A Warrants have a term of five years and are exercisable at $1.25 per share. The Series B Warrants have a term of 18 months, also exercisable at $1.25 per share. As of December 31, 2025, both the Series A and Series B Warrants have been fully exercised or written off.

On May 21, 2025, the Company issued an ELOC detachable warrant representing $20,250,000 to Alumni Capital LP. The ELOC was mutually terminated on December 11, 2025. As of December 31, 2025, warrants representing $1,680,505 remained outstanding under the ELOC warrant.

On August 13, 2025, in connection with the issuance of convertible notes to Alumni Capital LP, the Company issued detachable warrants representing an aggregate of $2,100,000.

On October 30, 2025, the Company issued pre-funded warrants to purchase up to 2,288,989 Ordinary Shares in connection with a registered direct offering.

On November 10, 2025, in connection with the Digital Asset Treasury initiative, the Company issued 49,120,000 pre-funded warrants.

On September 23, 2026, in connection with the EPA, the Company issued to Hudson a five-year common stock purchase warrant to purchase 1,171,875 Ordinary Shares at an exercise price of $0.01 per share, subject to adjustment under the warrant.

On September 23, 2026, the Company a five-year Dune Warrant to purchase 569,500 Ordinary Shares to Dune at an exercise price of $2.00 per share. On September 23, 2026, the Company issued a five-year FirstFire Warrant to purchase 280,500 Ordinary Shares to FirstFire at an exercise price of $2.00 per share.

(c) Issuances of Convertible Securities and Related Securities.

On September 23, 2026, the Company issued to Dune a secured convertible promissory note with a principal amount of up to $850,000, a purchase price of up to $775,000, a one-time interest charge at 12% and 18,000 Dune Commitment Shares. On September 23, 2026, the Company issued to FirstFire Global Opportunities Fund LLC a secured convertible promissory note with a principal amount of up to $850,000, a purchase price of up to $775,000, a one-time interest charge at 12% and 18,000 FirstFire Commitment Shares. The Dune and FirstFire Notes, warrants and commitment shares were issued or are issuable in transactions exempt from registration under Section 4(a)(2) of the Securities Act.

The issuances of the warrants, convertible securities and related securities described above were deemed or are expected to be exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder, as applicable, because they were made or will be made in transactions that did not involve a public offering. The recipients of those securities represented or will represent their intention to acquire the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof.

Item 8. Exhibits and Financial Statement Schedules

See Exhibit Index beginning on page II-6 of this registration statement.

The agreements included as exhibits to this registration statement contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties were made solely for the benefit of the other parties to the applicable agreement and (i) were not intended to be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) may have been qualified in such agreement by disclosure that was made to the other party in connection with the negotiation of the applicable agreement; (iii) may apply contract standards of “materiality” that are different from “materiality” under the applicable securities laws; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement.

We acknowledge that, notwithstanding the inclusion of the foregoing cautionary statements, we are responsible for considering whether additional specific disclosure of material information regarding material contractual provisions is required to make the statements in this registration statement not misleading.

Financial Statement Schedules.

Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in our combined and consolidated financial statements or the notes thereto.

Item 9. Undertakings.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

EXHIBIT INDEX

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Kuala Lumpur, Malaysia on September 29, 2026.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

ATTACHMENTS / EXHIBITS

COMMON STOCK PURCHASE WARRANT DATED SEPTEMBER 23, 2026 ISSUED TO HUDSON GLOBAL VENTURES, LLC

DUNE WARRANTS DATED SEPTEMBER 23, 2026 ISSUED TO DUNE EQUITY HOLDINGS LLC

DUNE SECURED PROMISSORY NOTE DATED SEPTEMBER 23, ISSUED TO DUNE EQUITY HOLDINGS LLC

FIRSTFIRE WARRANTS DATED SEPTEMBER 23, 2026 ISSUED TO FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC

FIRSTFIRE SECURED PROMISSORY NOTE DATED SEPTEMBER 23, 2026 ISSUED TO FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC

OPINION OF CAREY OLSEN (BVI) L.P., COUNSEL TO REGISTRANT

OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP, COUNSEL TO REGISTRANT

EQUITY PURCHASE AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND HUDSON GLOBAL VENTURES, LLC

REGISTRATION RIGHTS AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND HUDSON GLOBAL VENTURES, LLC

DUNE SECURITIES PURCHASE AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND DUNE EQUITY HOLDINGS LLC

DUNE SECURITY AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND DUNE EQUITY HOLDINGS LLC

FIRSTFIRE SECURITIES PURCHASE AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC

FIRSTFIRE SECURITY AGREEMENT DATED SEPTEMBER 23, 2026 BETWEEN THE REGISTRANT AND FIRSTFIRE GLOBAL OPPORTUNITIES FUND LLC

CONSENT OF WWC, PC

CONSENT OF SFAI MALAYSIA PLT

FILING FEE TABLE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ea030691101ex-fee_htm.xml